| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.26 | 0.07 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.28 | 0.08 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.08 |